Motzer RJ, Penkov K, Haanen JBAG, et al. JAVELIN Renal 101: A randomized, phase III study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC). ESMO 2018, abstract LBA6_PR.
ASCO GI 2020: nieuwe GE-behandelingen gepaard met betere kwaliteit van leven
apr 2020 | Maag-darm-leveroncologie